PCVX

Vaxcyte (PCVX)

About Vaxcyte (PCVX)

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Details

Daily high

$52.95

Daily low

$50.82

Price at open

52 Week High

$65.00

52 Week Low

$29.08

Market cap

7.5B

Dividend yield

0.00%

Volume

180

Avg. volume

1.4M

P/E ratio

-7.48

Vaxcyte News